부산대학교 도서관

Byline: Christie M. Lee (1), Margaret S. Herridge (2), Jonathan Y. Gabor (1), Catherine M. Tansey (2), Andrea Matte (2), Patrick J. Hanly (3) Keywords: Sleep; Insomnia; Critical illness; Adult respiratory distress syndrome Abstract: Purpose Sleep disruption is well recognized in the Intensive Care Unit. Poor sleep quality likely continues following discharge from hospital in several patients and becomes a chronic disorder in some. The aim of this study was to describe the etiology of chronic sleep complaints in survivors of ARDS. Methods Seven ARDS survivors with no previous sleep complaints who reported difficulty sleeping 6 months or more following discharge from hospital were evaluated. Sleep quality was assessed subjectively with a sleep history and the Insomnia Severity Index and objectively with polysomnography. Daytime sleepiness was assessed with the Epworth Sleepiness Scale. Results A chronic sleep disorder was identified in each patient who reported difficulty sleeping. The primary sleep disorder was chronic conditioned insomnia (5 patients), parasomnia (1 patient) and obstructive sleep apnea (1 patient). In addition, 4 patients had periodic leg movements, which was of uncertain clinical significance. Conclusion Chronic sleep disorders, which originate during the acute illness, are present in some ARDS survivors several months after discharge from hospital. If unrecognized, lack of treatment may contribute to impaired quality of life and incomplete rehabilitation from their critical illness. Author Affiliation: (1) Department of Medicine, University of Toronto, Toronto, Canada (2) Division of Critical Care, University Health Network, Toronto, Canada (3) Department of Medicine, University of Calgary, 1421 Health Sciences Centre, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada Article History: Registration Date: 01/09/2008 Received Date: 17/11/2007 Accepted Date: 19/07/2008 Online Date: 18/09/2008 Article note: Electronic supplementary material The online version of this article (doi: 10.1007/s00134-008-1277-3) contains supplementary material, which is available to authorized users.